Literature DB >> 15994783

Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats.

Marie-Eve Hamelin1, Kevin Yim, Katie H Kuhn, Rose P Cragin, Marina Boukhvalova, Jorge C G Blanco, Gregory A Prince, Guy Boivin.   

Abstract

Human metapneumovirus (hMPV) is a newly described member of the Paramyxoviridae family causing acute respiratory tract infections, especially in young children. We studied the pathogenesis of this viral infection in two experimental small animal models (BALB/c mice and cotton rats). Significant viral replication in the lungs of both animals was found following an intranasal challenge of 10(8) 50% tissue culture infectious doses (TCID50) and persisted for <2 and <3 weeks in the case of cotton rats and mice, respectively. Peak viral loads were found on day 5 postinfection in both mice (mean of 1.92 x 10(7) TCID50/g lung) and cotton rats (mean of 1.03 x 10(5) TCID50/g). Clinical symptoms consisting of breathing difficulties, ruffled fur, and weight loss were noted in mice only around the time of peak viral replication. Most significant pulmonary inflammatory changes and peak expression of macrophage inflammatory protein 1alpha, gamma interferon, and RANTES occurred at the time of maximal viral replication (day 5) in both models. Cellular infiltration occurred predominantly around and within alveoli and persisted for at least 21 days in mice, whereas it was more limited in time with more peribronchiolitis in cotton rats. Both animal models would be of great value in evaluating different therapeutic agents, as well as vaccine candidates against hMPV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994783      PMCID: PMC1168778          DOI: 10.1128/JVI.79.14.8894-8903.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Protection of BALB/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein.

Authors:  M Trudel; F Nadon; C Séguin; H Binz
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

2.  Respiratory syncytial virus affects pulmonary function in BALB/c mice.

Authors:  S M van Schaik; G Enhorning; I Vargas; R C Welliver
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

3.  Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus).

Authors:  G A Prince; J P Prieels; M Slaoui; D D Porter
Journal:  Lab Invest       Date:  1999-11       Impact factor: 5.662

4.  Animal models of respiratory syncytial virus infection.

Authors:  L G Byrd; G A Prince
Journal:  Clin Infect Dis       Date:  1997-12       Impact factor: 9.079

5.  High genetic diversity of the attachment (G) protein of human metapneumovirus.

Authors:  Nobuhisa Ishiguro; Takashi Ebihara; Rika Endo; Xiaoming Ma; Hideaki Kikuta; Hiroaki Ishiko; Kunihiko Kobayashi
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

6.  Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages.

Authors:  S Becker; J Quay; J Soukup
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

7.  The pathogenesis of respiratory syncytial virus infection in cotton rats.

Authors:  G A Prince; A B Jenson; R L Horswood; E Camargo; R M Chanock
Journal:  Am J Pathol       Date:  1978-12       Impact factor: 4.307

8.  Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-alpha) release and respiratory burst in human granulocytes.

Authors:  R Arnold; F Werner; B Humbert; H Werchau; W König
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

9.  Unilateral nasal infection of cotton rats with respiratory syncytial virus allows assessment of local and systemic immunity.

Authors:  S A Johnson; M G Ottolini; M E Darnell; D D Porter; G A Prince
Journal:  J Gen Virol       Date:  1996-01       Impact factor: 3.891

10.  Antigenic and genetic variability of human metapneumoviruses.

Authors:  Bernadette G van den Hoogen; Sander Herfst; Leo Sprong; Patricia A Cane; Eduardo Forleo-Neto; Rik L de Swart; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

View more
  45 in total

1.  Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection.

Authors:  Marie-Eve Hamelin; Gregory A Prince; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Modeling Human Respiratory Viral Infections in the Cotton Rat (Sigmodon hispidus).

Authors:  Jorge Cg Blanco; Marina S Boukhvalova; Daniel R Perez; Stefanie N Vogel; Adriana Kajon
Journal:  J Antivir Antiretrovir       Date:  2014-03-03

Review 3.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

4.  A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.

Authors:  Jennifer E Schuster; Reagan G Cox; Andrew K Hastings; Kelli L Boyd; Jay Wadia; Zhifeng Chen; Dennis R Burton; R Anthony Williamson; John V Williams
Journal:  J Infect Dis       Date:  2014-05-26       Impact factor: 5.226

5.  Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice.

Authors:  M Darniot; C Pitoiset; T Petrella; S Aho; P Pothier; C Manoha
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

6.  T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection.

Authors:  Deepthi Kolli; Efthalia L Bataki; Leanne Spetch; Antonieta Guerrero-Plata; Alan M Jewell; Pedro A Piedra; Gregg N Milligan; Roberto P Garofalo; Antonella Casola
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

7.  Acute clearance of human metapneumovirus occurs independently of natural killer cells.

Authors:  Sherry C Wen; Sharon J Tollefson; Monika Johnson; Pavlo Gilchuk; Kelli L Boyd; Bryan Shepherd; Sebastian Joyce; John V Williams
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

8.  Identification of human metapneumovirus-induced gene networks in airway epithelial cells by microarray analysis.

Authors:  X Bao; M Sinha; T Liu; C Hong; B A Luxon; R P Garofalo; A Casola
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

9.  The cotton rat model of respiratory viral infections.

Authors:  Marina S Boukhvalova; Gregory A Prince; Jorge C G Blanco
Journal:  Biologicals       Date:  2009-04-25       Impact factor: 1.856

10.  Effect of NMSO3 treatment in a murine model of human metapneumovirus infection.

Authors:  Leanne Spetch; Terry L Bowlin; Antonella Casola
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.